Brimonidine tartrate 0.025%
Allergy · OTC
OTCAllergyDecongestant
| Strength | 0.025% |
|---|---|
| Typical quantity | 7.5 mL bottle, OTC (Lumify) |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Selective alpha-2 agonist (redness relief) |
| Mechanism of action | Low-dose selective alpha-2 agonist; constricts conjunctival venules with minimal arteriolar effect, so far less rebound than imidazoline decongestants. |
| Indication / reason for use | OTC relief of ocular redness. |
| Usual adult dosing | 1 drop in the affected eye(s) every 6-8 h as needed. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses before use; reinsert after 10 min. |
| Common / important adverse effects | Minimal; rare mild irritation. Rebound redness uncommon at this concentration. |
| Contraindications & cautions | Caution with MAOIs / tricyclics; not for children <5 y; caution in severe cardiovascular disease. |
| Pregnancy / lactation | Limited data; low systemic exposure at this dose. |
| Trade names | Lumify |
| Practice notes | Distinct from the 0.1-0.2% glaucoma formulations, do not substitute. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.